In addition to its general anti-inflammatory and cardiotonic properties, deslanoside may exert its therapeutic effects in ALI by modulating Na+/K+-ATPase–associated signaling and downstream suppression of the NF-κB and NLRP3 inflammasome pathways. Here, NLRP3 is linked to acute respiratory distress syndrome.